Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinics-Reference-Cited by-同舟云学术

Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinics

Published:2019-05 Issue:5 Volume:78 Page:402-408
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Sarfo Fred S.,Castelnuovo Barbara,Fanti Iuri,Feldt Torsten,Incardona Francesca,Kaiser Rolf,Lwanga Isaac,Marrone Gaetano,Sonnerborg Anders,Tufa Tafese B.,Zazzi Maurizio,De Luca Andrea

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference40 articles.

1. Joint United Nations programme on HIV/AIDS (UNAIDS) AIDSInfo online database. Geneva, Switzerland: UNAIDS; 2015. Available from: www.aidsinfoonline.org. Accessed 26 December 2017.

2. Recommendations for a public health approach,2013

3. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review;Barth;Lancet Infect Dis,2010

4. Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy;Sarfo;PLoS One,2014

5. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in rural HIV treatment programme in KwaZulu-Natal, South Africa;Manasa;PLoS One,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network);Tropical Medicine and Infectious Disease;2023-04-23

2. Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program;Journal of the International Association of Providers of AIDS Care (JIAPAC);2023-01

3. Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia;HIV Medicine;2021-10-07

4. Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda;BMC Infectious Diseases;2021-08-16